SeekingAlpha · Aug 1, 2026
UCB SA (UCBJY) Q2 2026 Earnings Call Transcript
UCB SA (UCBJY) Q2 2026 Earnings Call July 30, 2026 8:00 AM EDTCompany ParticipantsYvonne Naughton - Head of Investor RelationsJean-Christophe Tellier - CEO...
UC
OTC · UCBJY
UCB S.A.
Healthcare · Biotechnology
$128.58
Up+$0.89 (+0.69%)
Updated Sep 4, 2026, 1:20 PM
SID Score
5.8/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 53.81B
- P/E ratio
- 34.37
- Dividend yield
- 0.61%
- 52-week range
- — – —
- Volume
- 6.66K
- Avg. volume
- 29.22K
Price performance
UCBJY price history
1M range · 0 trading sessions · Daily adjusted prices
UCBJY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest UCBJY news
The latest Smart Investors Daily articles mentioning UCBJY.
Stock researchCompany · Overview
UCBJY research
Overview
Company profile and research snapshot.
Company profile
UCB SA UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 14, 2026 | TD COWEN | Buy | — |
| Jul 13, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 13, 2026 | BERENBERG | Buy | — |
| Jul 7, 2026 | KBC SECURITIES | Buy | — |
| Jul 1, 2026 | ING FM | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 30, 2026
UCB SA 2026 Q2 - Results - Earnings Call Presentation
2026-07-30. The following slide deck was published by UCB SA in conjunction with their 2026 Q2 earnings call.
SeekingAlpha · Jul 17, 2026
UCB SA: From Rebuild To Re-Rating (Initiating Buy)
UCB SA is rated a Buy due to its successful pivot to high-growth immunology and neurology platforms. Learn more about UCBJF stock here.
Benzinga · Jul 8, 2026
UCB Data Reinforce Long-Term Promise For Weak Muscles Disorder
UCB presents data showing rozanolixizumab & zilucoplan deliver sustained symptom relief for generalized myasthenia gravis (gMG).
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
